Feng Zhang — Guangzhou University of Chinese Medicine

Area of research

Surgery · Pulmonary and Respiratory Medicine

Research interest

Research focused on Dissection (medical) and Statistical significance, with related work in Cetuximab, Refractory (planetary science), Placebo. Notable publications include 'Safety and Efficacy of the C-117 Formula for Vulnerable Carotid Artery Plaques (Spchim): A Randomized Double-Blind Controlled Pilot Study', 'Cetuximab combined with chemotherapy is beneficial for patients with advanced non-small cell lung cancer after EGFR-tyrosine kinase inhibitors failure', and 'Bilateral Carotid Dissection Caused by a Dog Bite: Case Report and Review of the Literature'.

Recent publications

Bilateral Carotid Dissection Caused by a Dog Bite: Case Report and Review of the Literature

Advanced ultrasound in diagnosis and therapy 2020cited by 1position: lastdoi

Safety and Efficacy of the C-117 Formula for Vulnerable Carotid Artery Plaques (Spchim): A Randomized Double-Blind Controlled Pilot Study

Evidence-based Complementary and Alternative Medicine 2019cited by 5position: middledoi

TEYSUNO™ (S-1) IS BENEFICIAL FOR EGFR-TKI REFRACTORY NSCLC PATIENTS

International Journal of Advanced Research 2016cited by 0position: firstdoi

Cetuximab combined with chemotherapy is beneficial for patients with advanced non-small cell lung cancer after EGFR-tyrosine kinase inhibitors failure.

PubMed 2015cited by 4position: first

Grants

No grants ingested yet.

Frequent collaborators

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Surgery · Pulmonary and Respiratory Medicine →